Notice Number: NOT-GM-12-117

Key Dates
Release Date: December 18, 2012

Issued by
National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to clarify the page limits of the Commercialization Plan in PAR-09-220 "Innovations in Biomedical Computational Science and Technology Initiative (SBIR[R43/R44])".

An error in the funding opportunity announcement (FOA) led to confusion about page limits for the Commercialization Plan in Fast-Track applications.

The corrected language is as follows:

Section IV.6 Other Submission Requirements - Original

SBIR Fast-Track Applications
The Fast-Track application must present a Commercialization Plan (maximum 15 pages) that addresses specific points as described in the SF424 (R&R) SBIR/STTR Application Guide.

Section IV.6 Other Submission Requirements - Corrected

SBIR Fast-Track Applications
The Fast-Track application must present a Commercialization Plan (maximum 12 pages) that addresses specific points as described in the SF424 (R&R) SBIR/STTR Application Guide.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Peter M. Lyster, Ph.D.
National Institute of General Medical Sciences
Division of Biomedical Technology, Bioinformatics, and Computational Biology
Telephone: 301.451.6446
Email: [email protected]